Iovance Biotherapeutics Reports FDA Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
Coinbase execs visit UAE to test potential of ‘strategic hub’ for international operations 3 weeks ago
Iovance Biotherapeutics Reports FDA Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
USPTO Issues Notice of Allowance to Enveric Biosciences for C4-Carboxylic Acid-Substituted Tryptamine Derivatives 6 days ago
Lifecore Biomedical Closes $150 Million New Financing Agreement and Signs New HA Fermentation Capacity Supply Agreement 1 week ago
Microbot Medical’s LIBERTY Achieves 100% Success Rate in Extensive Pre-Clinical Animal Study Performed in Europe 1 week ago
FDA Clears Phio Pharmaceuticals to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas 2 weeks ago
YS Biopharma Receives Phase 3 Clinical Trial Approval in Pakistan for PIKA Rabies Vaccine 2 weeks ago
LM Funding America Reports Q1 Results and Achieved Over 1,100% Year-Over-Year Revenue Growth 2 weeks ago
Aligos Therapeutics Enters Research Collaboration and Development Agreement with Xiamen Amoytop Biotech 2 weeks ago
New England Journal of Medicine Publishes DBV Technologies’ Phase 3 EPITOPE Trial Data Evaluating Viaskin Peanut in Toddlers 3 weeks ago